Postmenopausal estrogen therapy selectiv
โ
R Sherstha; C McKinley; P Russ; A Scherzinger; T Bronner; R Showalter; G T Evers
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 196 KB
The goal of this study was to determine whether use of postmenopausal estrogen (Premarin, Wyeth-Ayerst, Philadelphia, PA) in women with autosomal dominant polycystic kidney disease (ADPKD) increases liver, hepatic cyst, or kidney volume. We also determined whether clinical symptoms correlated with t